Literature DB >> 18411430

Breast-cancer stromal cells with TP53 mutations.

Cecilia Soussi Zander, Thierry Soussi.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18411430

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors.

Authors:  Karolina Edlund; Ola Larsson; Adam Ameur; Ignas Bunikis; Ulf Gyllensten; Bernard Leroy; Magnus Sundström; Patrick Micke; Johan Botling; Thierry Soussi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-24       Impact factor: 11.205

Review 2.  Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

Authors:  Yoav Shetzer; Alina Molchadsky; Varda Rotter
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

3.  Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer.

Authors:  Shojiro Kikuchi; Nobuaki Kaibe; Koji Morimoto; Hirokazu Fukui; Hirotaka Niwa; Yoshihiro Maeyama; Masashi Takemura; Masaki Matsumoto; Shoji Nakamori; Hiroto Miwa; Seiichi Hirota; Mitsuru Sasako
Journal:  Gastric Cancer       Date:  2014-06-08       Impact factor: 7.370

4.  Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.

Authors:  JeanMarie Houghton; Hanchen Li; Xueli Fan; Yingwang Liu; Jian Hua Liu; Varada P Rao; Theofilos Poutahidis; Christie L Taylor; Erin A Jackson; Christine Hewes; Stephen Lyle; Anna Cerny; Glennice Bowen; Jan Cerny; Nathan Moore; Evelyn A Kurt-Jones; Susan E Erdman
Journal:  Stem Cells Dev       Date:  2010-08       Impact factor: 3.272

Review 5.  When mutants gain new powers: news from the mutant p53 field.

Authors:  Ran Brosh; Varda Rotter
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

6.  Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies.

Authors:  Hongdo Do; Alexander Dobrovic
Journal:  Mol Cancer       Date:  2009-10-08       Impact factor: 27.401
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.